I am also looking forward to a shareholder letter. However, regardless of what it says, the majority of posters on this board will spin it as very negative, I’m fairly certain. Good luck!
I want to put it very clearly: the letter to shareholders can be saved directly without a clear statement on the current status of the Refresh II study. Has Refresh II died with the current stop (halt) of patient recruitment or are the requirements for resuming patient recruitment met or when will they be met definitely ?
Market Data 
Markets 
AI
